Paul Hopper

Advanced Biotherapy, Inc. operates as a development stage company. It focuses on the acquiring revenue generating companies or development stage companies through an asset acquisition or other financing. The firm is a subsidiary of Lime Financing Co. The company was founded on December 2, 1985 and is headquartered in Chicago, IL.

Part of CK Life Sciences International (Holdings), Inc., Polynoma LLC is an immuno-oncology focused biopharmaceutical company headquartered in San Diego, CA. Polynoma's lead asset is a novel polyvalent antigen vaccine, Seviprotimut-L, for the prevention of recurrence of melanoma. The vaccine has been safely administered in more than 1,000 patients. Polynoma is an immuno-oncology company developing a novel polyvalent antigen therapy for the treatment of melanoma. The company was founded by Paul A. Hopper.

Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on December 28, 1995 and is headquartered in Exton, PA.

Cappello Group, Inc. is an investment banking firm that provides advisory services such as mergers and acquisitions, equity financing, debt financing, specialized and project financing, strategic advisory, and restructuring. The private company is based in Los Angeles, CA and has subsidiaries in the United States. The company has industry expertise in business services, consumer products and services, energy, financial services, healthcare, industrials, real estate, gaming and hospitality, and technology, media & telecom. The company was founded by Alexander L. Cappello, who has been the CEO since incorporation.

Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia.

American Australian Association is a non-profit organization whose purpose is to promote friendship, cooperation and understanding between the peoples of the United States and Australia through a better understanding of their cultures and societies. The company was founded by Keith Murdoch in 1948 and is headquartered in New York, NY.

Medaire Ltd. provides medical and travel safety products and services to commercial airlines. The company was founded on April 16, 2002 and is headquartered in Farnborough, the United Kingdom.

Alpha Healthcare Ltd. is a private company headquartered in Mallow, Ireland, involved in management consulting services. It was founded by Paul A. Hopper.

Part of Cappello Group, Inc., Cappello Global LLC provides advisory services. The company is based in Santa Monica, CA. The CEO of the company is Richard Revelins.

Acuvax Ltd. is engaged in the research and development of cancer therapies and virus and vaccine development in Australia and North America. It is in process of acquiring Biolife Science Ltd, which is developing a vaccine for breast and gastric cancers. The company is headquartered in West Perth, Australia.

Pacific Council on International Policy operates as a foreign affairs firm. The firm specializes International Affairs, International Relations, Foreign Policy, Foreign Affairs, Public Policy, National Security, International Economics, Government, Professional Networking, Events, Non Profit, International Policy and International Business, Analysis. The company was founded in 1995 and is headquartered in Los Angeles, CA.

Part of Imugene Ltd., Biolife Science Ltd. is an Australian company that manufactures cancer therapeutic vaccines. The company is based in Brisbane, Australia. The company was founded by Brian Leedman. Biolife Science was acquired by Imugene Ltd. from Acuvax Ltd. on December 20, 2013 for $4.08 million.

Part of Prescient Therapeutics Ltd., Pathway Oncology Pty Ltd. holds a license to anti-cancer technology. The Australian company was founded by Paul A. Hopper. Pathway Oncology was acquired by Prescient Therapeutics Ltd. on May 30, 2014 for $1.74 million.

Vaxinia Pty Ltd. develops oncolytic cancer viruses. The company is headquartered in Australia.

Glioblast Pty Ltd. engages in neuro-oncology business. The company is headquartred in Sydney, Australia.

Radiopharm Theranostics (USA), Inc. is an American company founded in 2021 that develops radiopharmaceutical products for diagnostic and therapeutic uses.